CGT

16개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved16 programs
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 1

CD123 CAR-T cells (CD123 CAR-T cells)

Acute Myelocytic Leukemia · Acute Myelocytic Leukemia

#AcuteMyelocyticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 37Status Active
CGTLimited DatastaleStephan Grupp MD PhDPhase 1

CART123 (Anti-CD123 LV redirected T cells, Anti-CD123 LV redirected T cells (CART123))

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 8Status Recruiting
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 2

CD123 targeted CAR-NK cells (CD123 targeted CAR-NK cells)

Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 4Status Active
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

Anti-CD123 CAR NK cells (Anti-CD123 CAR NK cells)

AML (Acute Myeloid Leukemia); BPDCN (Blastic Plasmacytoid Dendritic Cell Neoplasm) · AML (Acute Myeloid Leukemia)

#AMLAcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleMustang Bio, Inc.Phase 1

Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes (Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes)

Adult Acute Myeloid Leukemia in Remission; Acute Biphenotypic Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleMustang Bio, Inc.Phase 1

Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes (Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes)

Adult Acute Myeloid Leukemia in Remission; Acute Biphenotypic Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 2

Autologous CD33/CD123 dual-target CAR-T module (Autologous CD33/CD123 dual-target CAR-T module)

Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia; Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing JD Biotech Co. LTD.Phase 1

CD123-CAR-NK cells (CD123-CAR-NK cells)

Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia Recurrent · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

CD123-CD33 cCAR T cells (CD123-CD33 cCAR T cells)

Hematologic Malignancy; Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleEssen BiotechPhase 2

CD123/CD33 CART (CD123/CD33 CART)

AML; Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleAffiliated Hospital to Academy …Phase 1

CD123CAR-41BB-CD3zeta-EGFRt-expressing T cells (CD123CAR-41BB-CD3zeta-EGFRt-expressing T cells)

Adult Acute Myeloid Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells (CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells)

Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 1

CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20 (Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20)

CD19 Negative B-cell Malignancies · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleWuhan Bio-Raid Biotechnology Co…Phase 1

Third-generation anti-CD123 CAR-T cells (Third-generation anti-CD123 CAR-T cells)

CD123+ Acute Myeloid Leukemia · CD123+ Acute Myeloid Leukemia

#CD123+AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

anti-CD123 CAR-T treatment (anti-CD123 CAR-T treatment)

Acute Leukemia; Acute Leukemia in Relapse · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued